CA2164961A1 - Glycosides fucosyles, inhibiteurs de l'adherence bacterienne - Google Patents

Glycosides fucosyles, inhibiteurs de l'adherence bacterienne

Info

Publication number
CA2164961A1
CA2164961A1 CA002164961A CA2164961A CA2164961A1 CA 2164961 A1 CA2164961 A1 CA 2164961A1 CA 002164961 A CA002164961 A CA 002164961A CA 2164961 A CA2164961 A CA 2164961A CA 2164961 A1 CA2164961 A1 CA 2164961A1
Authority
CA
Canada
Prior art keywords
beta
fuc
spacer
alpha
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002164961A
Other languages
English (en)
Inventor
Karin Ingeborg Eklind
Hans Roland Lonn
Anna-Karin Ulla Edit Tiden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2164961A1 publication Critical patent/CA2164961A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Dérivés glycosidiques de mono, di, tri ou oligosaccharides présentant au moins un groupe terminal dérivé du L-fucose. Ces composés sont efficaces dans la thérapie ou la prophylaxie chez l'homme d'états relatifs à l'infection de la muqueuse gastrique par l'Heliobacter pylori; ainsi que leur méthode de préparation et celle de compositions pharmaceutiques les contenant.
CA002164961A 1993-06-25 1994-06-17 Glycosides fucosyles, inhibiteurs de l'adherence bacterienne Abandoned CA2164961A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0761/93 1993-06-25
DK93761A DK76193D0 (da) 1993-06-25 1993-06-25 Kulhydratderivater

Publications (1)

Publication Number Publication Date
CA2164961A1 true CA2164961A1 (fr) 1995-01-05

Family

ID=8097261

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002164961A Abandoned CA2164961A1 (fr) 1993-06-25 1994-06-17 Glycosides fucosyles, inhibiteurs de l'adherence bacterienne

Country Status (9)

Country Link
EP (1) EP0706528A1 (fr)
JP (1) JPH08512026A (fr)
AU (1) AU7089194A (fr)
CA (1) CA2164961A1 (fr)
DK (1) DK76193D0 (fr)
IL (1) IL110074A0 (fr)
IS (1) IS4181A (fr)
LT (1) LT3446B (fr)
WO (1) WO1995000527A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014120799A1 (fr) * 2013-01-31 2014-08-07 Pioneer Hi-Bred International, Inc. Lipochitooligosaccharides synthétiques pour l'amélioration de la croissance et du rendement des plantes

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
JPH1160590A (ja) * 1997-08-22 1999-03-02 Yakult Honsha Co Ltd オリゴフコース誘導体又はオリゴラムノース誘導体及びその製造法
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
CN101291946B (zh) * 2005-08-09 2011-06-29 糖模拟物有限公司 对来自假单胞菌的pa-il凝集素、pa-iil凝集素或其两者的糖模拟物抑制剂
WO2012037034A1 (fr) 2010-09-14 2012-03-22 Glycomimetics, Inc. Antagonistes de l'e-sélectine
CA2858099C (fr) 2011-12-22 2020-12-15 Glycomimetics, Inc. Composes antagonistes de la selectine e, compositions et methodes d'utilisation
EP2692740A1 (fr) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Compositions de glycane, leurs procédés de préparation et leurs utilisations en tant que médicament
DK2928476T3 (en) 2012-12-07 2018-05-22 Glycomimetics Inc RELATIONSHIPS, COMPOSITIONS AND METHODS OF USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
DK3227310T3 (da) 2014-12-03 2019-09-30 Glycomimetics Inc Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer
WO2017127422A1 (fr) 2016-01-22 2017-07-27 Glycomimetics, Inc. Inhibiteurs glycomimétiques des lectines pa-il et pa-iil
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
WO2018068010A1 (fr) 2016-10-07 2018-04-12 Glycomimetics, Inc. Antagonistes de e-sélectine multimériques très puissants
EP3596096A1 (fr) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Dérivés de galactopyranosyle-cyclohexyle utilisés en tant qu'antagonistes d'e-sélectine
WO2019108750A1 (fr) 2017-11-30 2019-06-06 Glycomimetics, Inc. Méthodes de mobilisation de lymphocytes infiltrant la moelle et leurs utilisations
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3091454A1 (fr) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methodes de traitement de la leucemie aigue myeloide et d'etats pathologiques associes
CN112638944A (zh) 2018-08-23 2021-04-09 西进公司 抗tigit抗体
KR20210110645A (ko) 2018-12-27 2021-09-08 글리코미메틱스, 인크. 갈렉틴-3 억제 c-글리코사이드
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
DE3220427A1 (de) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg Ss-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
AU609999B2 (en) * 1988-06-21 1991-05-09 Marion Laboratories, Inc. Bismuth (phosph/sulf)ated saccharides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014120799A1 (fr) * 2013-01-31 2014-08-07 Pioneer Hi-Bred International, Inc. Lipochitooligosaccharides synthétiques pour l'amélioration de la croissance et du rendement des plantes
CN105101972A (zh) * 2013-01-31 2015-11-25 先锋国际良种公司 用于改善植物生长和产量的合成型脂质几丁寡糖

Also Published As

Publication number Publication date
EP0706528A1 (fr) 1996-04-17
WO1995000527A1 (fr) 1995-01-05
IL110074A0 (en) 1994-10-07
AU7089194A (en) 1995-01-17
IS4181A (is) 1994-12-26
DK76193D0 (da) 1993-06-25
JPH08512026A (ja) 1996-12-17
LT3446B (en) 1995-10-25
LTIP1978A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
CA2164961A1 (fr) Glycosides fucosyles, inhibiteurs de l'adherence bacterienne
US9446109B2 (en) Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri
US11191822B2 (en) Pneumococcal polysaccharide-protein conjugate composition
CZ341097A3 (cs) Sulfatované oligosacharidy, způsob jejich výroby a použití
JPH08502726A (ja) ３分枝性クラスタグリコシドの調製およびその用途
JPH11510490A (ja) ルイスｙエピトープの複合糖質の合成及びこれらの使用
JP2003527346A (ja) 合成オリゴマンノシド並びにその調製および使用
WO2004058304A1 (fr) Oligosaccharides et conjugues pour le traitement d'infections par bacterie pseudomonale
EP0126043B1 (fr) Dérivés de carbohydrates et compositions à usage thérapeutique ou diagnostique
JPH09183789A (ja) 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
JPH11506458A (ja) 旅行者の下痢の処置
Wu et al. Immunochemical studies on the N-acetyllactosamine β-(1→ 6)-linked trisaccharide specificity of Ricinus communis agglutinin
US20240024489A1 (en) Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof
EP3269385A1 (fr) Composition de conjugués de polysaccharide-protéine pneumococcique
US6238668B1 (en) Colon cancer KH-1 and N3 antigens
WO2000056343A1 (fr) Structures glucidiques de n-acetyl lactosamine fucosyle sialyle permettant d'inhiber l'adhesion bacterienne
EP4245764A1 (fr) Nouveaux dérivés glucidiques comme mimétiques des antigènes des groupes sanguins a et b
WO1993002709A1 (fr) Conjugues comprenant un recepteur, destines a cibler des medicaments et autres agents
CA2531023C (fr) Glycoconjuges et leur utilisation comme vaccins potentiels contre une infection provoquee par shigella flexneri
CN117651707A (zh) 新的合成的tlr4受体激动剂
CA2434685A1 (fr) Nouvelle approche d'elaboration de glycopeptides a base de polysaccharide o-specifique du serotype 2a de shigella flexneri
CN113429443A (zh) 一种双唾液酸-甘露寡糖复合物及其合成方法
Jiao An anti-Clostridium difficile vaccine: chemical synthesis of the pentasaccharide repeating unit of polysaccharide PS-I
Ariosa Alvarez Towards the synthesis of V. Cholerae O1 antigens and GQ1bα [GQ1b-alpha] ganglioside as potential therapeutic agents: structural chemistry and characterization
MXPA97008289A (en) Preparation and use of oligosacaridos sulfata

Legal Events

Date Code Title Description
FZDE Discontinued